IllinoisIllinois requires a 340B study if a related bill becomes law
If House Bill 2371, as amended, becomes law, the Department of Insurance must study Illinois providers' use of 340B discounts and report findings to lawmakers.
What it does
If House Bill 2371, as amended, becomes law, the Department of Insurance must study how Illinois providers and drugmakers use 340B discounts, including effects on state health programs.
Providers and drugmakers must answer the department's study requests. Missing information may bring daily fines, with lower fines for certain hospitals and 340B grantees.
The department must report combined study findings to lawmakers and the Governor without naming individual providers or drugmakers.
If House Bill 2371 becomes law, the Attorney General may take Section 15 violations to court; a judge could order damages, penalties, or other relief.
Argument forA statewide study could help lawmakers understand how 340B discounts affect patients and communities, including how providers use savings to support care.
Argument againstProviders and drugmakers could face daily fines for late or incomplete reports, adding pressure to gather and submit detailed financial and patient information.
More detail
The Department of Insurance must study how Illinois 340B providers and drug manufacturers take part in the federal discount program. The study covers Illinois 340B covered entities and pharmaceutical manufacturers doing business in Illinois. The study must examine effects on state health programs, including Medicaid and the State Employees Group Insurance Program. The Act takes effect only if House Bill 2371, as amended by Senate Amendment No. 2, becomes law; its effective date is the later of that bill's effective date or this Act's becoming law. The Department must begin the study as soon as practical after this Act takes effect.
340B providers and drug manufacturers must provide information the Department of Insurance requests for its study. The duty applies to all Illinois 340B covered entities and pharmaceutical manufacturers doing business in Illinois. A fine may apply if all requested information is not submitted within 30 calendar days after the Department's deadline. The fine is $500 per day, or $100 per day for hospitals with fewer than 100 licensed beds, Critical Access Hospitals, Safety-Net Hospitals, and 340B grantees. Fine money goes to a state fund for health care access, sustainability, and support for the 340B program. The Department sets the response deadline; a fine may apply when information remains missing 30 calendar days after that deadline.
The Department of Insurance must send lawmakers and the Governor a report of the study's findings. The report covers findings about 340B covered entities and pharmaceutical manufacturers. The report must combine findings across providers and drugmakers and may not identify any one of them. The Department must note information requests that were not answered and address whether providers should report yearly or every two years. The report is due by July 1, 2028. The Act is repealed on July 1, 2032.
If House Bill 2371 becomes law, the Attorney General may bring a court case over violations of that law's Section 15. This applies only if House Bill 2371 becomes law and concerns violations of its Section 15. The Attorney General must have reasonable cause to believe a violation has occurred or is occurring. A court finding a violation may allow orders to stop the conduct, money damages, a civil penalty of up to $1,000 per violation, or other relief.
Where do you stand?
Choose your position
Tell your reps
Take a position to see your representatives and ways to contact them.
Where it stands
- Introduced
- Passed House
- Passed Senate
- To Governor
- Became Law
Looking ahead
No hearings or votes scheduled.
History
- 2026
- Aug 7Public Act . . . . . . . . . 104-0769Latest
- Aug 7Effective Date August 7, 2026
- Aug 7Governor J. B. Pritzker ApprovedBecame Law
- Jun 26Sent to the GovernorTo Governor
- Jun 1Added as Alternate Co-Sponsor Sen. Elgie R. Sims, Jr.
- Jun 1Added Co-Sponsor Rep. Nicolle Grasse
- Jun 1Added Co-Sponsor Rep. Angelica Guerrero-Cuellar
- Jun 1Added Co-Sponsor Rep. Lilian Jiménez
- Jun 1Added Co-Sponsor Rep. Robyn Gabel
- Jun 1Added Co-Sponsor Rep. Suzanne M. Ness
- Jun 1Added Co-Sponsor Rep. Thaddeus Jones
- Jun 1Added Co-Sponsor Rep. Bob Morgan
- Jun 1Added Co-Sponsor Rep. Marcus C. Evans, Jr.
- Jun 1Added Co-Sponsor Rep. Mary Beth Canty
- Jun 1Added Co-Sponsor Rep. Carol Ammons
- Jun 1Added Co-Sponsor Rep. Debbie Meyers-Martin
- Jun 1Added Co-Sponsor Rep. Yolonda Morris
- Jun 1Added Co-Sponsor Rep. Michael Crawford
- Jun 1Added Co-Sponsor Rep. Sonya M. Harper
- Jun 1Added Co-Sponsor Rep. Justin Slaughter
- Jun 1Added Co-Sponsor Rep. Rita Mayfield
- Jun 1Added Co-Sponsor Rep. William "Will" Davis
- Jun 1Added Co-Sponsor Rep. Lisa Davis
- Jun 1Added Co-Sponsor Rep. Jehan Gordon-Booth
- Jun 1Added Co-Sponsor Rep. Kimberly Du Buclet
- Jun 1Added Chief Co-Sponsor Rep. La Shawn K. Ford
- Jun 1Added Chief Co-Sponsor Rep. Anna Moeller
- May 31Passed Both Houses
- Vote recorded Third Reading. Result: pass.Upper
- Vote recorded Concurrence, Amendment 1. Result: pass.Lower
- May 31House Concurs
- May 31Senate Committee Amendment No. 1 House Concurs 106-008-000
- May 31Senate Committee Amendment No. 1 Motion to Concur Recommends Be Adopted Rules Committee; 004-000-000
- May 31Added Co-Sponsor Rep. Emanuel "Chris" Welch
- May 31Senate Committee Amendment No. 1 Motion to Concur Referred to Rules Committee
- May 31Senate Committee Amendment No. 1 Motion Filed Concur Rep. Camille Y. Lilly
- May 31Added Chief Co-Sponsor Rep. Martha Deuter
- May 31Placed on Calendar Order of Concurrence Senate Amendment(s) 1
- May 31Arrived in HouseMinor
- May 31Added as Alternate Co-Sponsor Sen. Mary Edly-Allen
- May 31Added as Alternate Co-Sponsor Sen. Robert F. Martwick
- May 31Third Reading - Passed; 057-000-000Passed Senate
- May 31Added as Alternate Co-Sponsor Sen. Michael W. Halpin
- May 30Placed on Calendar Order of 3rd Reading May 31, 2026
- Vote recorded Do Pass. Result: pass.Upper
- Vote recorded Do Pass, Amendment 1. Result: pass.Upper
- May 30Second ReadingMinor
- May 30Added as Alternate Chief Co-Sponsor Sen. Bill Cunningham
- May 30Placed on Calendar Order of 2nd ReadingMinor
- May 30Do Pass as Amended Executive; 013-000-000
- May 30Senate Committee Amendment No. 1 AdoptedMajor
- May 30Waive Posting Notice
- May 30Senate Committee Amendment No. 1 Assignments Refers to Executive
- May 30Senate Committee Amendment No. 1 Referred to Assignments
- May 30Senate Committee Amendment No. 1 Filed with Secretary by Sen. David KoehlerMinor
- May 30Assigned to ExecutiveMinor
- May 30Rule 2-10 Committee/3rd Reading Deadline Established As May 31, 2026
- May 29Added Co-Sponsor Rep. Michael J. Kelly
- May 29Added Co-Sponsor Rep. Barbara Hernandez
- May 29Referred to Assignments
- May 29First ReadingMinor
- May 29Chief Senate Sponsor Sen. David Koehler
- May 29Placed on Calendar Order of First ReadingMinor
- May 29Arrive in SenateMinor
- May 28Added Co-Sponsor Rep. Laura Faver Dias
- Vote recorded Third Reading. Result: pass.Lower
- Vote recorded Do Pass, Amendment 2. Result: pass.Lower
- May 28Added Co-Sponsor Rep. Norma Hernandez
- May 28Added Co-Sponsor Rep. Janet Yang Rohr
- May 28Added Co-Sponsor Rep. Margaret A. DeLaRosa
- May 28Added Co-Sponsor Rep. Maurice A. West, II
- May 28Added Co-Sponsor Rep. Maura Hirschauer
- May 28Added Co-Sponsor Rep. Dagmara Avelar
- May 28Third Reading - Short Debate - Passed 075-037-000Passed House
- May 28Placed on Calendar Order of 3rd Reading - Short Debate
- May 28House Floor Amendment No. 3 Adopted by Voice VoteMajor
- May 28House Floor Amendment No. 2 AdoptedMajor
- May 28House Floor Amendment No. 3 Recommends Be Adopted Rules Committee; 003-002-000Minor
- May 28House Floor Amendment No. 3 Referred to Rules Committee
- May 28House Floor Amendment No. 3 Filed with Clerk by Rep. Camille Y. LillyMinor
- May 28House Floor Amendment No. 2 Recommends Be Adopted Executive Committee; 008-004-000Minor
- May 27House Floor Amendment No. 2 Rules Refers to Executive Committee
- May 26Held on Calendar Order of Second Reading - Short DebateMinor
- Vote recorded Do Pass. Result: pass.Lower
- May 26Second Reading - Short DebateMinor
- May 26House Floor Amendment No. 2 Referred to Rules Committee
- May 26House Floor Amendment No. 2 Filed with Clerk by Rep. Camille Y. LillyMinor
- May 26Placed on Calendar 2nd Reading - Short DebateMinor
- May 26Do Pass as Amended / Short Debate Executive Committee; 008-004-000
- May 26House Committee Amendment No. 1 Adopted in Executive Committee; by Voice VoteMajor
- May 25Motion to Suspend Rule 21 - Prevailed 066-029-000
- May 25Motion Filed to Suspend Rule 21 Executive Committee; Rep. Elizabeth "Lisa" Hernandez
- May 25House Committee Amendment No. 1 Rules Refers to Executive Committee
- May 22House Committee Amendment No. 1 Referred to Rules Committee
- May 22House Committee Amendment No. 1 Filed with Clerk by Rep. Camille Y. LillyMinor
- May 22Committee/3rd Reading Deadline Extended-Rule May 31, 2026
- May 22Assigned to Executive CommitteeMinor
- May 21Chief Sponsor Changed to Rep. Camille Y. Lilly
- Mar 27Rule 19(a) / Re-referred to Rules Committee
- Feb 11Assigned to Executive CommitteeMinor
- Jan 14Referred to Rules Committee
- Jan 14First ReadingMinor
- Jan 7Filed with the Clerk by Rep. Curtis J. Tarver, IIIntroduced
Healthcare